$6.01
Candel Therapeutics is a biotechnology business based in the US. Candel Therapeutics shares (CADL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.95 – a decrease of 1% over the previous week. Candel Therapeutics employs 42 staff and has a trailing 12-month revenue of around $31,000.
Our top picks for where to buy Candel Therapeutics stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Candel Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CADL. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Candel Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Candel Therapeutics stock price (NASDAQ: CADL)
Use our graph to track the performance of CADL stocks over time.Candel Therapeutics shares at a glance
Latest market close | $5.95 |
---|---|
52-week range | $0.66 - $14.30 |
50-day moving average | $6.28 |
200-day moving average | $5.16 |
Wall St. target price | $11.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.70 |
Is it a good time to buy Candel Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Candel Therapeutics price performance over time
Historical closes compared with the close of $5.95 from 2024-10-15
1 week (2024-10-10) | -1.00% |
---|---|
1 month (2024-09-17) | -15.30% |
3 months (2024-07-17) | -9.44% |
6 months (2024-04-17) | 9.38% |
1 year (2023-10-17) | 561.11% |
---|---|
2 years (2022-10-17) | 138.00% |
3 years (2021-10-15) | 9.83 |
5 years (2019-10-13) | N/A |
Candel Therapeutics financials
Revenue TTM | $31,000 |
---|---|
Gross profit TTM | $-20,662,000 |
Return on assets TTM | -52.31% |
Return on equity TTM | -480.68% |
Profit margin | 0% |
Book value | $-0.32 |
Market Capitalization | $190.9 million |
TTM: trailing 12 months
Candel Therapeutics share price volatility
Over the last 12 months, Candel Therapeutics's shares have ranged in value from as little as $0.66 up to $14.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Candel Therapeutics's is -0.937. This would suggest that Candel Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Candel Therapeutics has bucked the trend.
To put Candel Therapeutics's beta into context you can compare it against those of similar companies.
- ESSA Pharma (EPIX.US): 1.838
- Homology Medicines (FIXX.US): -0.107
- Catabasis Pharmaceuticals (CATB.US): 1.6632
Candel Therapeutics overview
Candel Therapeutics, Inc. , a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent high-grade glioma. It also develops the"enLIGHTEN Discovery Platform, a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc.
Frequently asked questions
nullWhat percentage of Candel Therapeutics is owned by insiders or institutions?
Currently 30.854% of Candel Therapeutics shares are held by insiders and 20.183% by institutions. How many people work for Candel Therapeutics?
Latest data suggests 42 work at Candel Therapeutics. When does the fiscal year end for Candel Therapeutics?
Candel Therapeutics's fiscal year ends in December. Where is Candel Therapeutics based?
Candel Therapeutics's address is: 117 Kendrick Street, Needham, MA, United States, 02494 What is Candel Therapeutics's ISIN number?
Candel Therapeutics's international securities identification number is: US1374041093
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question